Prevalence, components and associated demographic and lifestyle factors of the metabolic syndrome in type 2 diabetes mellitus

Journal of Diabetes and Metabolic Disorders

Volumn 13, Issue 1, 2014, Pages

  Mogre, Victor ^a   Salifu, Zenabankara S ^a   Abedandi, Robert ^a  

^a UNIVERSITY FOR DEVELOPMENT STUDIES   (Ghana)

Author keywords

Clinical factors; Demographic factors; Ghana; Metabolic syndrome; Tamale; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE;

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY WEIGHT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIET RESTRICTION; FEMALE; GHANA; GHANAIAN; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; RISK FACTOR; TEACHING HOSPITAL; WAIST CIRCUMFERENCE;

EID: 84908136971     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-13-80     Document Type: Article

References (44)

1. Alberti K, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition: a consensus statement from the international diabetes federation. Diabet Med 2006, 23:469-480. 10.1111/j.1464-5491.2006.01858.x, 16681555.
2. Zimmet P, Alberti K, Serrano Ríos M. A new International Diabetes Federation (IDF) worldwide definition of the metabolic syndrome: the rationale and the results. Rev Esp Cardiol 2005, 58:1371-1375.
3. Alberti G, Zimmet P, Shaw J, Grundy SM. The IDF Consensus Worldwide Definition of the Metabolic Syndrome 2006, Brussels: International Diabetes Federation.
4. Stern MP, Williams K, González-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diabetes Care 2004, 27:2676-2681. 10.2337/diacare.27.11.2676, 15505004.
5. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005, 111:1448-1454. 10.1161/01.CIR.0000158483.13093.9D, 15781756.
6. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003, 52:1210-1214. 10.2337/diabetes.52.5.1210, 12716754.
7. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes the San Antonio heart study. Diabetes Care 2003, 26:3153-3159. 10.2337/diacare.26.11.3153, 14578254.
8. Marchesini G, Forlani G, Cerrelli F, Manini R, Natale S, Baraldi L, Ermini G, Savorani G, Zocchi D, Melchionda N. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with type 2 diabetes. Diabet Med 2004, 21:383-387. 10.1111/j.1464-5491.2004.01115.x, 15049944.
9. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M. Prevalence of insulin resistance in metabolic disorders: the Bruneck study. Diabetes 1998, 47:1643-1649. 10.2337/diabetes.47.10.1643, 9753305.
10. Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr 2010, 2:4. 10.1186/1758-5996-2-4, 2832622, 20180980.
11. Kengne AP, Limen SN, Sobngwi E, Djouogo CF, Nouedoui C. Metabolic syndrome in type 2 diabetes: comparative prevalence according to two sets of diagnostic criteria in sub-Saharan Africans. Diabetol Metab Syndr 2012, 4:22-22. 10.1186/1758-5996-4-22, 3407752, 22650602.
12. Mogre V, Abedandi R, Salifu ZS. Distorted self-perceived weight status and underestimation of weight status in diabetes mellitus type 2 patients. PLoS One 2014, 9:e95165. 10.1371/journal.pone.0095165, 3988156, 24736567.
13. WHO Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications 1999, Geneva, Switzerland: WHO, Report of a WHO Consultation, Retrieved from http://whqlibdoc.who.int/hq/1999/who_ncd_ncs_99.2.pdf, WHO.
14. WHO Waist Circumference and Waist-Hip Ratio 2008, Geneva, Switzerland: WHO, Report of a WHO Expert Consultation, Retrieved from http://whqlibdoc.who.int/publications/2011/9789241501491_eng.pdf, WHO.
15. WHO Obesity: Preventing and Managing the Global Epidemic 2000, Geneva, Switzerland: WHO, Report of a WHO Consultation, Retrieved from http://whqlibdoc.who.int/trs/WHO_TRS_894.pdf?ua=1, WHO.
16. Okafor CI. Metabolic syndrome in Africa: current trends. Indian J Endocrinol Metab 2012, 16:56-66. 10.4103/2230-8210.91191, 3263198, 22276253.
17. Faergeman O. The atherosclerosis epidemic: methodology, nosology, and clinical practice. Am J Cardiol 2001, 88:4-7.
18. Fezeu L, Balkau B, Kengne A-P, Sobngwi E, Mbanya J-C. Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis 2007, 193:70-76. 10.1016/j.atherosclerosis.2006.08.037, 1961628, 17011567.
19. Alebiosu CO, Odusan BO. Metabolic syndrome in subjects with type-2 diabetes mellitus. J Natl Med Assoc 2004, 96:817. 2568360, 15233492.
20. Adediran O, Edo A, Jimoh A, Ohwovoriole A. Prevalence of the metabolic syndrome among Nigerians with type 2 diabetes. Diabetes Int 2007, 15:13-14.
21. Isezuo S, Ezunu E. Demographic and clinical correlates of metabolic syndrome in Native African type-2 diabetic patients. J Natl Med Assoc 2005, 97:557. 2568734, 15868776.
22. Isezuo S. Is high density lipoprotein cholesterol useful in diagnosis of metabolic syndrome in native Africans with type 2 diabetes?. Ethn Dis 2005, 15:6.
23. Makuyana D, Gomo Z, Munyombwe T, Matenga J, Hakim J. Metabolic syndrome disorders in urban black Zimbabweans with type 2 diabetes mellitus. Cent Afr J Med 2004, 50:24.
24. Kalk W, Joffe B. The metabolic syndrome, insulin resistance, and its surrogates in African and white subjects with type 2 diabetes in South Africa. Metab Syndr Relat Disord 2008, 6:247-255. 10.1089/met.2008.0003, 19067527.
25. Kelliny C, William J, Riesen W, Paccaud F, Bovet P. Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol 2008, 7:27. 10.1186/1475-2840-7-27, 2556312, 18801172.
26. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J. The metabolic syndrome in the West Bank population an urban-rural comparison. Diabetes Care 2001, 24:275-279. 10.2337/diacare.24.2.275, 11213878.
27. Balkau B, Charles M-A, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metabol 2002, 28:364-376.
28. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, Cerai SP, Pagano G, Cavallo-Perin P. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes the Casale Monferrato study. Diabetes Care 2004, 27:2689-2694. 10.2337/diacare.27.11.2689, 15505006.
29. Raman R, Gupta A, Pal SS, Ganesan S, Venkatesh K, Kulothungan V, Sharma T. Prevalence of metabolic syndrome and its influence on microvascular complications in the Indian population with type 2 diabetes mellitus: Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14). Diabetol Metab Syndr 2010, 2:67. 10.1186/1758-5996-2-67, 2993661, 21067623.
30. Abdul-Ghani M, Nawaf G, Fawaz G, Itzhak B, Minuchin O, Vardi P. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome. IMAJ-RAMAT GAN- 2006, 8:378.
31. Nahar S, Rahman M, Ullah M, Debnath B, Sultana N, Farhad C. Prevalence of metabolic syndrome in newly diagnosed type 2 diabetes mellitus. Cardiovasc J 2011, 4:17-25.
32. Dhanaraj E, Bhansali A, Jaggi S, Dutra P, Jain S, Tiwari P, Ramarao P. Prevalence and predictors of metabolic syndrome in non-obese Asian Indians with newly detected type 2 diabetes mellitus. J Indian Med Assoc 2008, 106:366-368. 370-362.
33. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 2002, 287:356-359. 10.1001/jama.287.3.356, 11790215.
34. Kumar SV, Nagesh A, Leena M, Shravani G, Chandrasekar V. Incidence of metabolic syndrome and its characteristics of patients attending a diabetic outpatient clinic in a tertiary care hospital. J Nat Sci Biol Med 2013, 4:57. 10.4103/0976-9668.107261, 3633304, 23633836.
35. Puepet FH, Ohwovoriole AE. Prevalence of risk factors for diabetes mellitus in a non-diabetic population in Jos, Nigeria. Niger J Med 2008, 17:71-74.
36. Shimajiri Y, Tsunoda K, Furuta M, Kadoya Y, Yamada S, Nanjo K, Sanke T. Prevalence of metabolic syndrome in Japanese type 2 diabetic patients and its significance for chronic vascular complications. Diabetes Res Clin Pract 2008, 79:310-317. 10.1016/j.diabres.2007.08.026, 17933413.
37. Surana S, Shah D, Gala K, Susheja S, Hoskote S, Gill N, Joshi S, Panikar V. Prevalence of metabolic syndrome in an urban Indian diabetic population using the NCEP ATP III guidelines. JAPI 2008, 56:865-868.
38. Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens E, Pyörälä K. Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 2004, 47:1245-1256.
39. Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787. 10.1038/414782a, 11742409.
40. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willet WC, Rosner BA, Speizer FE, Manson JE. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women the nurses' health study. Am J Epidemiol 1997, 145:614-619. 10.1093/oxfordjournals.aje.a009158, 9098178.
41. Engelgau MM, Thompson TJ, Herman WH, Boyle JP, Aubert RE, Kenny SJ, Badran A, Sous ES, Ali MA. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes: diagnostic criteria and performance revisited. Diabetes Care 1997, 20:785-791. 10.2337/diacare.20.5.785, 9135943.
42. Alberti K. The clinical implications of impaired glucose tolerance. Diabet Med 1996, 13:927-937. 10.1002/(SICI)1096-9136(199611)13:11<927::AID-DIA279>3.0.CO;2-E, 8946150.
43. McCance D, Hanson R, Pettitt D, Bennett P, Hadden D, Knowler W. Diagnosing diabetes mellitus-do we need new criteria?. Diabetologia 1997, 40:247-255.
44. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004, 109:706-713. 10.1161/01.CIR.0000115514.44135.A8, 14970104.